vimarsana.com
Home
Live Updates
IGC Pharma Announces Patient Enrollment at Neurostudies in P
IGC Pharma Announces Patient Enrollment at Neurostudies in P
IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
-- Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's --
...
Related Keywords
Canada ,
Florida ,
United States ,
Port Charlotte ,
American ,
Ram Mukunda ,
Liliana Montoya ,
George Li ,
Neurostudies Inc ,
Pharma Inc ,
Exchange Commission ,
Principal Investigator ,
Risk Factors ,
Annual Report ,